Qilong Wu

Person

Shanghai, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Polyomavirus neutralizing antibodies
- Patent number 12,077,571
- Issue date Sep 3, 2024
- Novartis AG
- Johanna Abend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polyomavirus neutralizing antibodies
- Patent number 11,639,378
- Issue date May 2, 2023
- Novartis AG
- Johanna Abend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 11,591,404
- Issue date Feb 28, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Regulatable chimeric antigen receptor
- Patent number 11,578,130
- Issue date Feb 14, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Polyomavirus neutralizing antibodies
- Patent number 11,161,894
- Issue date Nov 2, 2021
- Novartis AG
- Johanna Abend
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-BCMA chimeric antigen receptor
- Patent number 11,084,880
- Issue date Aug 10, 2021
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cancer using a CD33 chimeric antigen receptor
- Patent number 10,851,166
- Issue date Dec 1, 2020
- Novartis AG
- Hilmar Erhard Ebersbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 10,703,819
- Issue date Jul 7, 2020
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polyomavirus neutralizing antibodies
- Patent number 10,654,914
- Issue date May 19, 2020
- Novartis AG
- Johanna Abend
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human mesothelin chimeric antigen receptors and uses thereof
- Patent number 10,640,569
- Issue date May 5, 2020
- Novartis AG
- Gregory Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Targeting cytotoxic cells with chimeric receptors for adoptive immu...
- Patent number 10,577,417
- Issue date Mar 3, 2020
- Novartis AG
- Gregory Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of cancer using a CLL-1 chimeric antigen receptor
- Patent number 10,568,947
- Issue date Feb 25, 2020
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polyomavirus neutralizing antibodies
- Patent number 10,450,366
- Issue date Oct 22, 2019
- Novartis AG
- Johanna Abend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polyomavirus neutralizing antibodies
- Patent number 10,435,460
- Issue date Oct 8, 2019
- Novartis AG
- Johanna Abend
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Regulatable chimeric antigen receptor
- Patent number 10,287,354
- Issue date May 14, 2019
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
- Patent number 10,174,095
- Issue date Jan 8, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polyomavirus neutralizing antibodies
- Patent number 9,862,760
- Issue date Jan 9, 2018
- Novartis AG
- Johanna Abend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 9,815,901
- Issue date Nov 14, 2017
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CD33 chimeric antigen receptor
- Patent number 9,777,061
- Issue date Oct 3, 2017
- Novartis AG
- Hilmar Erhard Ebersbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
POLYOMAVIRUS NEUTRALIZING ANTIBODIES
- Publication number 20230399382
- Publication date Dec 14, 2023
- Novartis AG
- Johanna ABEND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20230220090
- Publication date Jul 13, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
REGULATABLE CHIMERIC ANTIGEN RECEPTOR
- Publication number 20230026049
- Publication date Jan 26, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Polyomavirus Neutralizing Antibodies
- Publication number 20220363735
- Publication date Nov 17, 2022
- Novartis AG
- Johanna ABEND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...
- Publication number 20220064316
- Publication date Mar 3, 2022
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20210139595
- Publication date May 13, 2021
- Novartis AG
- Hilmar Erhard Ebersbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20210002377
- Publication date Jan 7, 2021
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20200215171
- Publication date Jul 9, 2020
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYOMAVIRUS NEUTRALIZING ANTIBODIES
- Publication number 20200190167
- Publication date Jun 18, 2020
- Novartis AG
- Johanna ABEND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REGULATABLE CHIMERIC ANTIGEN RECEPTOR
- Publication number 20190263914
- Publication date Aug 29, 2019
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING 5 HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RE...
- Publication number 20190153061
- Publication date May 23, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYOMAVIRUS NEUTRALIZING ANTIBODIES
- Publication number 20190071488
- Publication date Mar 7, 2019
- Novartis AG
- Johanna ABEND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYOMAVIRUS NEUTRALIZING ANTIBODIES
- Publication number 20190002533
- Publication date Jan 3, 2019
- Johanna ABEND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR B CELL PRECONDITIONING IN CAR THERAPY
- Publication number 20180334490
- Publication date Nov 22, 2018
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20180312595
- Publication date Nov 1, 2018
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
POLYOMAVIRUS NEUTRALIZING ANTIBODIES
- Publication number 20180079799
- Publication date Mar 22, 2018
- Novartis AG
- Johanna ABEND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20180044423
- Publication date Feb 15, 2018
- Novartis AG
- Hilmar Erhard Ebersbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMU...
- Publication number 20170260268
- Publication date Sep 14, 2017
- Gregory Beatty
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
POLYOMAVIRUS NEUTRALIZING ANTIBODIES
- Publication number 20170088605
- Publication date Mar 30, 2017
- Novartis AG
- Johanna ABEND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REGULATABLE CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160311907
- Publication date Oct 27, 2016
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
- Publication number 20160311917
- Publication date Oct 27, 2016
- Novartis AG
- Gregory Beatty
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160096892
- Publication date Apr 7, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160068601
- Publication date Mar 10, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160051651
- Publication date Feb 25, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...
- Publication number 20160046724
- Publication date Feb 18, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Polyomavirus neutralizing antibodies

Polyomavirus neutralizing antibodies

Treatment of cancer using a CD123 chimeric antigen receptor

Regulatable chimeric antigen receptor

Polyomavirus neutralizing antibodies

Anti-BCMA chimeric antigen receptor

Treatment of cancer using a CD33 chimeric antigen receptor

Treatment of cancer using a CD123 chimeric antigen receptor

Polyomavirus neutralizing antibodies

Human mesothelin chimeric antigen receptors and uses thereof

Targeting cytotoxic cells with chimeric receptors for adoptive immu...

Treatment of cancer using a CLL-1 chimeric antigen receptor

Polyomavirus neutralizing antibodies

Polyomavirus neutralizing antibodies

Regulatable chimeric antigen receptor

Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor

Polyomavirus neutralizing antibodies

Treatment of cancer using a CD123 chimeric antigen receptor

Treatment of cancer using a CD33 chimeric antigen receptor

Patents Applicationslast 30 patents

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

Polyomavirus Neutralizing Antibodies

TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...

TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING 5 HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RE...

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

METHODS FOR B CELL PRECONDITIONING IN CAR THERAPY

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR

TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMU...

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...